| 紫杉醇联合顺铂治疗复发性宫颈癌的临床观察 |
| |
| 引用本文： | Yingqiu Song,Guiling Li,Fang Zhu,Fangzheng Zhou,Sheng Zhang,Jing Wang,Zhongyuan Ying.紫杉醇联合顺铂治疗复发性宫颈癌的临床观察[J].中德临床肿瘤学杂志,2007,6(3):P282-P284. |
| |
| 作者姓名： | Yingqiu Song Guiling Li Fang Zhu Fangzheng Zhou Sheng Zhang Jing Wang Zhongyuan Ying |
| |
| 作者单位： | Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430023, China |
| |
| 摘 要： | Objective： To observe the efficacy and toxicities of paclitaxel plus cisplatin in the treatment of recurrent cervical cancer. Methods： Twenty-three patients with a diagnosis of recurrent cervical cancer were eligible. Three-weekly chemotherapy regimen consisted of paclitaxel 135-150 mg/m^2 infusion for 3 h on day 1, cisplatin 25 mg/m^2 infusion on day 1 to 3. All patients received at least two cycles treatment. Results： The response rates was 47.8%, including CR 2 cases （8.7%）, PR 9 cases （39.1%）. The major toxicity included neutropenia, nausea vomiting, arthralgia, myalgia and alopecia. Conclusion： Paclitaxel combined with cisplatin is an effective therapy with acceptable adverse reactions for recurrent cervical cancer.
|
| 关 键 词： | 化学疗法 子宫颈癌 反复发作 治疗方法 |
| 收稿时间： | 26 January 2007 |
| 修稿时间： | 2007-02-262007-03-07 |
Clinical study of paclitaxel plus cisplatin in the treatment of recurrent cervical cancer |
| |
| Yingqiu?Song,Guiling?Li,Fang?Zhu,Fangzheng?Zhou,Sheng?Zhang,Jing?Wang,Zhongyuan?Ying.Clinical study of paclitaxel plus cisplatin in the treatment of recurrent cervical cancer[J].The Chinese-German Journal of Clinical Oncology,2007,6(3):P282-P284. |
| |
| Authors: | Yingqiu Song Guiling Li Fang Zhu Fangzheng Zhou Sheng Zhang Jing Wang Zhongyuan Ying |
| |
| Institution: | (1) Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430023, China |
| |
| Abstract: | Objective:To observe the efficacy and toxicities of paclitaxel plus cisplatin in the treatment of recurrent cervical cancer.Methods:Twenty-three patients with a diagnosis of recurrent cervical cancer were eligible.Three-weekly chemotherapy reqimen consisted of paclitaxel 135-150 mg/m2 infusion for 3 h on day 1.cisplatin 25 mg/m2 infusion on day 1 to 3.All patients received at least two cycles treatment.Results:The response rates was 47.8%,including CR 2 cases(8.7%),PR9 cases(39.1%).The major toxicity included neutropenia,nausea vomiting,arthralgia,myalgia and alopecia.Conclusion:Paclitaxel combined with cisplatin is an effective therapy with acceptable adverse reactions for recurrent cervical cancer. |
| |
| Keywords: | paclitaxel cisplatin chemotherapy recurrent cervical cancer |
| 本文献已被 CNKI 维普 万方数据 SpringerLink 等数据库收录！ |
|
